Evie Stergiakouli1, Anita Thapar2, George Davey Smith1. 1. Medical Research Council (MRC) Integrative Epidemiology Unit (IEU) at the University of Bristol, University of Bristol, Bristol, United Kingdom. 2. Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff, Wales.
Abstract
IMPORTANCE: Acetaminophen (paracetamol) is used by a large proportion of pregnant women. Research suggests that acetaminophen use in pregnancy is associated with abnormal fetal neurodevelopment. However, it is possible that this association might be confounded by unmeasured behavioral factors linked to acetaminophen use. OBJECTIVE: To examine associations between offspring behavioral problems and (1) maternal prenatal acetaminophen use, (2) maternal postnatal acetaminophen use, and (3) partner's acetaminophen use. DESIGN, SETTING, AND PARTICIPANTS: From February 2015 to March 2016, we collected and analyzed data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective birth cohort. We studied 7796 mothers enrolled in ALSPAC between 1991 and 1992 along with their children and partners. EXPOSURES: Acetaminophen use was assessed by questionnaire completion at 18 and 32 weeks of pregnancy and when the child was 61 months old. MAIN OUTCOMES AND MEASURES: Maternal reports of behavioral problems using the Strengths and Difficulties Questionnaire (SDQ) when the children were 7 years old. We estimated risk ratios for behavioral problems in children after prenatal, postnatal, and partner's exposure to acetaminophen and mutually adjusted each association. RESULTS: Maternal prenatal acetaminophen use at 18 (n = 4415; 53%) and 32 weeks of pregnancy (n = 3381; 42%) was associated with higher odds of having conduct problems (risk ratio [RR], 1.42; 95% CI, 1.25-1.62) and hyperactivity symptoms (RR, 1.31; 95% CI, 1.16-1.49), while maternal acetaminophen use at 32 weeks was also associated with higher odds of having emotional symptoms (RR, 1.29; 95% CI, 1.09-1.53) and total difficulties (RR, 1.46; 95% CI, 1.21-1.77). This was not the case for maternal postnatal (n = 6916; 89%) or partner's (n = 3454; 84%) acetaminophen use. We found the associations between maternal prenatal acetaminophen use and all the SDQ domains unchanged even after adjusting for maternal postnatal or partner's acetaminophen use. CONCLUSIONS AND RELEVANCE: Children exposed to acetaminophen prenatally are at increased risk of multiple behavioral difficulties, and the associations do not appear to be explained by unmeasured behavioral or social factors linked to acetaminophen use insofar as they are not observed for postnatal or partner's acetaminophen use. Although these results could have implications for public health advice, further studies are required to replicate the findings and to understand mechanisms.
IMPORTANCE: Acetaminophen (paracetamol) is used by a large proportion of pregnant women. Research suggests that acetaminophen use in pregnancy is associated with abnormal fetal neurodevelopment. However, it is possible that this association might be confounded by unmeasured behavioral factors linked to acetaminophen use. OBJECTIVE: To examine associations between offspring behavioral problems and (1) maternal prenatal acetaminophen use, (2) maternal postnatal acetaminophen use, and (3) partner's acetaminophen use. DESIGN, SETTING, AND PARTICIPANTS: From February 2015 to March 2016, we collected and analyzed data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospective birth cohort. We studied 7796 mothers enrolled in ALSPAC between 1991 and 1992 along with their children and partners. EXPOSURES: Acetaminophen use was assessed by questionnaire completion at 18 and 32 weeks of pregnancy and when the child was 61 months old. MAIN OUTCOMES AND MEASURES: Maternal reports of behavioral problems using the Strengths and Difficulties Questionnaire (SDQ) when the children were 7 years old. We estimated risk ratios for behavioral problems in children after prenatal, postnatal, and partner's exposure to acetaminophen and mutually adjusted each association. RESULTS: Maternal prenatal acetaminophen use at 18 (n = 4415; 53%) and 32 weeks of pregnancy (n = 3381; 42%) was associated with higher odds of having conduct problems (risk ratio [RR], 1.42; 95% CI, 1.25-1.62) and hyperactivity symptoms (RR, 1.31; 95% CI, 1.16-1.49), while maternal acetaminophen use at 32 weeks was also associated with higher odds of having emotional symptoms (RR, 1.29; 95% CI, 1.09-1.53) and total difficulties (RR, 1.46; 95% CI, 1.21-1.77). This was not the case for maternal postnatal (n = 6916; 89%) or partner's (n = 3454; 84%) acetaminophen use. We found the associations between maternal prenatal acetaminophen use and all the SDQ domains unchanged even after adjusting for maternal postnatal or partner's acetaminophen use. CONCLUSIONS AND RELEVANCE: Children exposed to acetaminophen prenatally are at increased risk of multiple behavioral difficulties, and the associations do not appear to be explained by unmeasured behavioral or social factors linked to acetaminophen use insofar as they are not observed for postnatal or partner's acetaminophen use. Although these results could have implications for public health advice, further studies are required to replicate the findings and to understand mechanisms.
Authors: Laurence de Fays; Karen Van Malderen; Karen De Smet; Javier Sawchik; Veerle Verlinden; Jamila Hamdani; Jean-Michel Dogné; Bernard Dan Journal: Dev Med Child Neurol Date: 2015-04-07 Impact factor: 5.449
Authors: Evangelia Stergiakouli; Marian Hamshere; Peter Holmans; Kate Langley; Irina Zaharieva; Ziarah Hawi; Lindsey Kent; Michael Gill; Nigel Williams; Michael J Owen; Michael O'Donovan; Anita Thapar Journal: Am J Psychiatry Date: 2012-02 Impact factor: 18.112
Authors: Abigail Fraser; Corrie Macdonald-Wallis; Kate Tilling; Andy Boyd; Jean Golding; George Davey Smith; John Henderson; John Macleod; Lynn Molloy; Andy Ness; Susan Ring; Scott M Nelson; Debbie A Lawlor Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Zeyan Liew; Marianthi-Anna Kioumourtzoglou; Andrea L Roberts; Éilis J O'Reilly; Alberto Ascherio; Marc G Weisskopf Journal: Am J Epidemiol Date: 2019-04-01 Impact factor: 4.897
Authors: Andréa D Bertoldi; Sheryl L Rifas-Shiman; Alexandra Crispim Boing; Tatiane da Silva Dal Pizzol; Vanessa Iribarrem Avena Miranda; Marysabel Pinto Telis Silveira; Mariângela Freitas Silveira; Marlos R Domingues; Ina S Santos; Diego G Bassani; Luciana Tovo-Rodrigues; Emily Oken Journal: Paediatr Perinat Epidemiol Date: 2020-01-22 Impact factor: 3.980
Authors: Mary R Hutson; Anna L Keyte; Miriam Hernández-Morales; Eric Gibbs; Zachary A Kupchinsky; Ioannis Argyridis; Kyle N Erwin; Kelly Pegram; Margaret Kneifel; Paul B Rosenberg; Pavle Matak; Luke Xie; Jörg Grandl; Erica E Davis; Nicholas Katsanis; Chunlei Liu; Eric J Benner Journal: Sci Signal Date: 2017-10-10 Impact factor: 8.192
Authors: Hannah E Laue; Raphael Cassoulet; Nadia Abdelouahab; Yasmine K Serme-Gbedo; Anne-Sandrine Desautels; Kasey J M Brennan; Jean-Philippe Bellenger; Heather H Burris; Brent A Coull; Marc G Weisskopf; Larissa Takser; Andrea A Baccarelli Journal: Toxicol Sci Date: 2019-01-01 Impact factor: 4.849